Curis, Inc. - Common Stock (NQ:CRIS)

0.4445 -0.0256 (-5.45%)

Streaming Delayed Price Updated: 1:30 PM EDT, Jun 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Curis, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Curis: Q4 Earnings Insights ↗

February 24, 2022

Curis (NASDAQ:CRIS) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings Curis...

Via Benzinga

Earnings Preview For Curis ↗

February 23, 2022

Curis (NASDAQ:CRIS) is set to give its latest quarterly earnings report on Thursday, 2022-02-24. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

58 Biggest Movers From Yesterday ↗

January 07, 2022

Gainers Eargo, Inc. (NASDAQ: EAR) shares climbed 59.7% to close at $7.28 on Thurs after the company announced the Department of Justice confirmed to it that the previously-...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 06, 2022

Gainers Eargo (NASDAQ:EAR) stock increased by 50.0% to $6.84 during Thursday's regular session. The current volume of 90.4 million shares is 5474.6% of Eargo's...

Via Benzinga

33 Stocks Moving In Thursday's Mid-Day Session ↗

January 06, 2022

Gainers Eargo, Inc. (NASDAQ: EAR) shares jumped 50.8% to $6.88 after the company announced the Department of Justice confirmed to it that the previously-announced criminal probe...

Via Benzinga

Mid-Morning Market Update: Markets Open Lower; Walgreens Tops Q1 Views ↗

January 06, 2022

Following the market opening Thursday, the Dow traded down 0.52% to 36,217.32 while the NASDAQ fell 1.09% to 14,935.90. The S&P also fell, dropping 0.52% to 4,676.00. The U.S...

Via Benzinga

Curis (CRIS) Q3 2021 Earnings Call Transcript ↗

November 10, 2021

CRIS earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2021 ↗

October 13, 2021

Upgrades DA Davidson upgraded the previous rating for Columbia Banking System Inc (NASDAQ:

Via Benzinga

Why Curis Stock Perked Up in August ↗

September 08, 2021

The biotech's shares rode the wave of buyout speculation higher last month.

Via The Motley Fool

Curis, Inc. (NASDAQ:CRIS) Investor Alert: Investigation over Potential Wrongdoing ↗

August 24, 2021

San Diego, CA -- (SBWIRE) -- 08/24/2021 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Curis, Inc.

Via SBWire

Return on Capital Employed Overview: Curis ↗

August 20, 2021

Pulled from Benzinga Pro data Curis (NASDAQ:CRIS) reported Q2 sales of $2.29 million. Earnings fell to a loss of $10.65 million, resulting in a 21.02% decrease from last quarter....

Via Benzinga

Curis (CRIS) Q2 2021 Earnings Call Transcript ↗

August 04, 2021

CRIS earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Recap: Curis Q2 Earnings ↗

August 03, 2021

Shares of Curis (NASDAQ:CRIS) were flat in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 29.41% year over year to...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

July 08, 2021

Gainers Dare Bioscience (NASDAQ:DARE) sto...

Via Benzinga

Analyzing Curis's Unusual Options Activity ↗

July 08, 2021

Shares of Curis (NASDAQ:CRIS) saw some unusual options activity on Thursday. Following the unusual option alert, the stock price moved up to $7.66. Sentiment: BULLISH Option...

Via Benzinga

NASDAQ:CRIS Investor Notice: Investigation over Possible Securities Laws Violations by Curis, Inc. ↗

July 07, 2021

San Diego, CA -- (SBWIRE) -- 07/07/2021 -- Curis, Inc. is under investigation over potential securities laws violations by Curis, Inc. in connection with certain financial statements.

Via SBWire

Kymera Therapeutics' KT-413 Shows Encouraging Preclinical Anti-Cancer Activity ↗

June 21, 2021

Kymera Therapeutics Inc (NASDAQ: KYMR) has announced new preclinical data on its IRAKIMiD degrader KT-413's potential as both a monotherapy and in combination...

Via Benzinga

Why Curis Fell Off a Cliff on Friday ↗

June 11, 2021

The company will bring a lower dose of an important pipeline drug into a phase 2 clinical trial.

Via The Motley Fool

Mid-Afternoon Market Update: Crude Oil Rises 1%; Janux Therapeutics Shares Jump ↗

June 11, 2021

Toward the end of trading Friday, the Dow traded down 0.1% to 34,432.88 while the NASDAQ rose 0.16% to 14,043.26. The S&P also rose, gaining 0.04% to 4,240.72. The U.S. has...

Via Benzinga

Topics Stocks

64 Biggest Movers From Friday ↗

June 14, 2021

Gainers Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares gained...

Via Benzinga

Topics Initial Public Offering

46 Stocks Moving In Friday's Mid-Day Session ↗

June 11, 2021

Gainers Kanzhun Limited (NASDAQ: BZ) shares surged 77.4% to $33.70 after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares jumped 73.3% to $15.67...

Via Benzinga

Topics Initial Public Offering

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 11, 2021

Gainers Novan (NASDAQ:NOVN) stock rose 71.04% to $15.46 during Friday's regular session. As of 12:30 EST, Novan's stock is trading at a volume of 109.3 million,...

Via Benzinga

Mid-Day Market Update: Markets Mixed; Novan Shares Spike Higher ↗

June 11, 2021

Midway through trading Friday, the Dow traded down 0.07% to 34,442.46 while the NASDAQ rose 0.09% to 14,033.42. The S&P also rose, gaining 0.01% to 4,239.73. The U.S. has the...

Via Benzinga

Topics Stocks

Curis Shares Drop After Updated CA-4948 Data From Mid-Stage Blood Cancer Trial ↗

June 11, 2021

Curis Inc (NASDAQ: CRIS) has announced updated data from its ongoing Phase 1/2 study of CA-4948 in patients with acute myeloid leukemia (AML) or high-risk...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 11, 2021

Gainers GBS (NASDAQ:GBS) stock increased by 41.04% to $5.12 during Friday's pre-market session. Novan (NASDAQ:NOVN) stock increased by 36.5% to $12.34. The company...

Via Benzinga

The Daily Biotech Pulse: Vertex Shelves Mid-Stage Study, Precigen & Novan Jump On Data, Hematology Conference, Janux Debuts ↗

June 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 10) Alexion Pharmaceuticals,...

Via Benzinga

Why Curis Stock Crashed on Thursday ↗

May 13, 2021

The swoon came shortly after some very good news for the company.

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 13, 2021

Gainers MultiPlan (NYSE:MPLN) stock increased by 17.31% to $7.21 during Thursday's regular session. Trading volume for MultiPlan's stock is 4.0 million as of 12:30...

Via Benzinga

The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck ↗

June 07, 2021

Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical Oncology meeting got underway during the week,...

Via Benzinga

77 Biggest Movers From Yesterday ↗

May 14, 2021

Gainers AMC Entertainment Holdings, Inc. (NYSE: AMC) shares surged 23.7% to close at $12.77. Moxian, Inc. (NASDAQ: MOXC) jumped 23.6% to close at $9.52. Repro Med Systems, Inc...

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.